Only 2.7% of the US population has gotten a Pfizer or Moderna by valent COVID booster so uptake is increasingly waning right. That market is falling off and I wouldn't expect Pfizer ever is able to reap the 37 billion that it got last year from its COVID-19 vaccineSo they're gonna have to strengthen the pipeline elsewhere. So ultimately Pfizer has said that it wants to do a flu and and COVID combo but I think we're still a couple years away from that.
Bloomberg News Legal Reporter Jef Feeley explains why Elon Musk is reviving his original deal to buy Twitter at the price of $54.20 a share. Bloomberg Balance of Power Anchor David Westin discusses Micron's plan for a $100 billion for semiconductor factory in New York. Bloomberg Businessweek Editor Joel Weber and Bloomberg News U.S. Health Care Reporter Riley Griffin provide the details of Riley's Businessweek Magazine story Pfizer Needs to Prove That It’s Ready to Move On From Covid-19. Stewart Glickman, Head of Energy Research at CFRA, talks about investing in energy firms in this inflationary environment. And we Drive to the Close with Sylvia Jablonski, CEO at Defiance ETFs.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.